Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001033475-25-000004
Filing Date
2025-02-14
Accepted
2025-02-14 10:22:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6413
2 EXHIBIT A Exhibit_A.pdf EX-1 31016
  Complete submission text file 0001033475-25-000004.txt   51376
Mailing Address 277 SOUTH WASHINGTON STREET SUITE 350 ALEXANDRIA VA 22314
Business Address 277 SOUTH WASHINGTON STREET SUITE 350 ALEXANDRIA VA 22314 (202) 659-4427
AVENIR CORP (Filed by) CIK: 0001033475 (see all company filings)

EIN.: 541146619 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 0000

Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Subject) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-81910 | Film No.: 25624486
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)